Ocular Oncology News

The FDA granted de novo classification to the SeCore CDx HLA Sequencing System for use as a companion diagnostic with Kimmtrak for metastatic or unresectable uveal melanoma, according to a Thermo Fisher Scientific press release.

A 73-year-old man presented to the emergency department at Tufts Medical Center with shortness of breath and blurry vision in the right eye for the past 2 months.

CHICAGO — AU-011 helped preserve vision in patients with early-stage choroidal melanoma, according to a study presented at the American Academy of Ophthalmology meeting.

GENEVA — Two new classification systems allow for improved stratification of patients with retinoblastoma, according to study results presented at World Cancer Congress.

CHICAGO — OCT accurately staged skin cancers, allowing for better diagnosis of basal cell carcinoma, prediction of margins and improved planning for Mohs surgery, according to a study presented here.

MONTEREY, Calif. — Progress is being made in the advancement of vision-sparing treatments for uveal melanoma, according to Alison Skalet, MD, PhD.

MONTEREY, Calif. — The aqueous humor is important for diagnosis, prognosis and objective monitoring of treatment response in cases of retinoblastoma, Jesse L. Berry, MD, told colleagues here.

MONTEREY, Calif. — Interferon alpha-2b, 5-fluorouracil and mitomycin C can all be used topically for conjunctival tumors, Lauren A. Dalvin, MD, said at the Women in Ophthalmology Summer Symposium.

Women who use taxane chemotherapy agents may be at a higher risk to develop epiphora, optic neuropathy and cystoid macular edema, according to a study.

In patients with class 2 uveal melanoma tumors, predicted metastasis-free survival by a gene expression profile test was shown to be worse than that observed in a cohort study and worse than that reported in the literature.